Texas Governor Greg Abbott announced plans to release sterile screwworm flies to eradicate the parasite, which was first detected in a Texas calf on June 3.
Year: 2026
India Cabinet Approves EV Scheme to Incentivise Trucks and Buses in NCR
The Union Cabinet approved a two-year scheme giving incentives for truck and bus owners in the National Capital Region to switch to electric or BS-VI vehicles.
AIIMS Study Shows Air Pollution Disrupts Foetal Growth Via Protein Suppression
An AIIMS Delhi study identified the molecular pathway through which PM2.5 air pollution suppresses a key protein needed for healthy foetal development.
7 of 9 Planetary Boundaries Now Breached With Ocean Acidification Newest Crossing
India’s 2026 State of Environment report warns that ocean acidification has joined six other breached planetary boundaries threatening Earth’s stability.
Poor Sleep in Midlife Tied to Worse Wellbeing and Cognitive Function Years Later
Research presented at SLEEP 2026 found that inadequate sleep during midlife was associated with significantly worse cognitive and emotional wellbeing in later years.
Remibrutinib Resolves Chronic Inducible Urticaria in New Clinical Trial Data
New results from the EAACI 2026 congress showed remibrutinib effectively resolved chronic inducible urticaria, a difficult-to-treat allergic skin condition.
Space Travel Research Reveals New Insights Into Cancer Cell Biology
Scientists studying astronaut health data found that the conditions of space travel offer unexpected insights into how cancer cells behave and adapt.
Cannabis Psychosis Shows Distinct Symptom Pattern Separate From Schizophrenia
A new study published in 2026 found that cannabis-induced psychosis presents a distinct clinical profile that differs significantly from schizophrenia symptoms.
Dupilumab Outperforms Omalizumab in High-Biomarker Asthma Trial
At the EAACI 2026 conference, dupilumab demonstrated superior outcomes over omalizumab in patients with severe asthma characterised by high biomarker levels.
Blinatumomab Outperforms Chemotherapy in High-Risk B-Cell Leukaemia
Data from the EHA 2026 conference shows blinatumomab significantly outperformed standard chemotherapy in treating high-risk B-cell acute lymphoblastic leukaemia.